Isaac Manke

Insider Reports History

Location
C/O New Leaf Venture Partners, 7 Times Square, Suite 3502, New York, NY
Signature
/s/ Eric Bell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Isaac Manke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
OnKure Therapeutics, Inc. Director Class A Common Stock 15.3K $40.3K $2.63 Sep 30, 2025 Direct
Q32 Bio Inc. Director Stock Option (Right to Buy) 53.5K $35.3K $13.42 Oct 23, 2025 Direct
OnKure Therapeutics, Inc. Director Stock Option (right to buy) 7.65K May 28, 2025 Direct

Insider Reports Filed by Isaac Manke

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QTTB Q32 Bio Inc. Oct 23, 2025 1 $0 4 Oct 27, 2025 Director
OKUR OnKure Therapeutics, Inc. Sep 30, 2025 1 $0 4 Oct 2, 2025 Director
OKUR OnKure Therapeutics, Inc. Jun 30, 2025 1 $0 4 Jul 2, 2025 Director
OKUR OnKure Therapeutics, Inc. May 28, 2025 1 $0 4 May 30, 2025 Director
OKUR OnKure Therapeutics, Inc. Mar 31, 2025 1 $0 4 Apr 2, 2025 Director
QTTB Q32 Bio Inc. Jan 15, 2025 7 $0 4 Feb 27, 2025 Director
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 1 $0 4 Oct 8, 2024 Director
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 0 $0 3 Oct 8, 2024 Director
QTTB Q32 Bio Inc. Apr 1, 2024 1 $35.3K 4 Sep 30, 2024 Director
QTTB Homology Medicines, Inc. Mar 25, 2024 1 $0 4 Mar 27, 2024 Director
QTTB Homology Medicines, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 Director